Suppr超能文献

[老年人心律失常治疗的风险与指征]

[Dangers of and indications for anti-arrhythmia therapy in the aged].

作者信息

Follath F

出版信息

Fortschr Med. 1983 Sep 1;101(33):1460-4.

PMID:6629271
Abstract

Preexisting anomalies of impulse formation and conduction, cardiac failure, myocardial ischemia and abnormal peripheral vasoregulation predispose the elderly patient to frequent and often severe side-effects of antiarrhythmic drugs. Paroxysmal supraventricular tachycardia in patients with sick sinus syndrome can be especially difficult to treat, as most antiarrhythmics further prolong the sinus node recovery time. Thus, implantation of a pacemaker is often necessary to prevent symptomatic bradycardia. Concomitant treatment with diuretics or digitalis also increases the risk of drug induced ventricular dysrhythmias. Interaction between quinidine, verapamil, amiodarone and digoxin may be the reason for drug toxicity. To compensate for decreased renal or metabolic drug clearances antiarrhythmic treatment in elderly patients should be initiated with lower doses than usual.

摘要

既往存在的冲动形成和传导异常、心力衰竭、心肌缺血及外周血管调节异常,使老年患者易频繁且常发生抗心律失常药物的严重副作用。病窦综合征患者的阵发性室上性心动过速尤其难以治疗,因为大多数抗心律失常药物会进一步延长窦房结恢复时间。因此,通常需要植入起搏器以预防症状性心动过缓。同时使用利尿剂或洋地黄也会增加药物诱发室性心律失常的风险。奎尼丁、维拉帕米、胺碘酮和地高辛之间的相互作用可能是药物毒性的原因。为补偿肾或代谢药物清除率的降低,老年患者抗心律失常治疗应从低于常用剂量开始。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验